0.9% Saline or Balanced Crystalloid Fluids for Critically III Patients: SPLIT Decision?

被引：0
|
作者：
Galm, Brandon [1 ]
Bagshaw, Sean M. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2016年 / 68卷 / 01期
关键词：
ACUTE KIDNEY INJURY; RENAL BLOOD-FLOW; INTENSIVE-CARE; PLASMA-LYTE; CONSENSUS CONFERENCE; HYDROXYETHYL STARCH; ILL PATIENTS; RESUSCITATION; CHLORIDE; MORTALITY;
D O I：
10.1053/j.ajkd.2016.02.028
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 14
页数：4
相关论文
共 50 条
  • [41] 0.9 % Saline vs 6 % HES 130/0.4 for fluid resuscitation in critically ill patients (vol 8, pg 347, 2013)
    Nenna, Giulia
    Costantino, Giorgio
    INTERNAL AND EMERGENCY MEDICINE, 2013, 8 (07) : 643 - 643
  • [42] Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial (vol 402, pg 105, 2023)
    不详
    LANCET, 2023, 402 (10395): : 26 - 26
  • [43] The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients
    Wilkes, NJ
    Woolf, R
    Mutch, M
    Mallett, SV
    Peachey, T
    Stephens, R
    Mythen, MG
    ANESTHESIA AND ANALGESIA, 2001, 93 (04): : 811 - 816
  • [44] Isotonic balanced fluid versus 0.9% saline in patients with moderate to severe traumatic brain injury: A double-blinded randomised controlled trial
    Poh, Khadijah
    Bustam, Aida
    Hasan, Mohd Shahnaz
    Yunos, Nor'azim Mohd
    Cham, Chun Yoong
    Lim, Fang Jen
    Zahedi, Ahmad Zulkarnain Ahmad
    Zambri, Aliyah
    Azhar, Muhaimin Noor
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2024, 77 : 106 - 114
  • [45] Correction to: Statistical analysis plan for better evidence for selecting transplant fluids (BEST-fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation
    Elaine M. Pascoe
    Steven J. Chadban
    Magid A. Fahim
    Carmel M. Hawley
    David W. Johnson
    Michael G. Collins
    Trials, 23
  • [46] Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis
    Zampieri, Fernando G.
    Cavalcanti, Alexandre B.
    Tanna, Gian Luca Di
    Damiani, Lucas P.
    Hammond, Naomi E.
    Machado, Flavia R.
    Micallef, Sharon
    Myburgh, John
    Ramanan, Mahesh
    Venkatesh, Balasubramanian
    Rice, Todd W.
    Semler, Matthew W.
    Young, Paul J.
    Finfer, Simon
    LANCET RESPIRATORY MEDICINE, 2024, 12 (03): : 237 - 246
  • [47] Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis
    Liu, Chao
    Lu, Guangming
    Wang, Dong
    Lei, Yi
    Mao, Zhi
    Hu, Pan
    Hu, Jie
    Liu, Rui
    Han, Dong
    Zhou, Feihu
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (11): : 2072 - 2078
  • [48] Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial (vol 314, pg 1701, 2015)
    Young, P.
    Bailey, M.
    Beasley, R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (23): : 2570 - 2570
  • [49] Statistical analysis plan for better evidence for selecting transplant fluids (BEST-fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation (vol 23, 52, 2022)
    Pascoe, Elaine M.
    Chadban, Steven J.
    Fahim, Magid A.
    Hawley, Carmel M.
    Johnson, David W.
    Collins, Michael G.
    TRIALS, 2022, 23 (01)
  • [50] Comparison of Balanced Crystalloids versus Normal Saline in Critically Ill Patients: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
    Chen, Yi
    Gao, Yongli
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 783 - 799
12345